Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjögren's syndrome in Taiwan

Annals of the Rheumatic Diseases

Volumn 71, Issue 4, 2012, Pages 524-527

  Weng, Meng Yu ^a   Huang, Yu Tung ^b   Liu, Ming Fei ^a   Lu, Tsung Hsueh ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; COHORT ANALYSIS; COLON CANCER; CONTROLLED STUDY; FEMALE; HIGH RISK PATIENT; HUMAN; KIDNEY CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MULTIPLE MYELOMA; NASOPHARYNX CANCER; NATIONAL HEALTH INSURANCE; OVARY CANCER; PANCREAS CANCER; PRIMARY SJOEGREN SYNDROME; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; SEX DIFFERENCE; SJOEGREN SYNDROME; SKIN CANCER; STOMACH CANCER; TAIWAN; THYROID CANCER; UTERINE CERVIX CANCER;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; SEX DISTRIBUTION; SJOGREN'S SYNDROME; TAIWAN;

EID: 84857913542     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2011-200402     Document Type: Article

References (37)

1. Pillemer SR, Matteson EL, Jacobsson LT, et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota. Mayo Clin Proc 2001;76:593-9. (Pubitemid 32525134)
2. Plesivcnik Novljan M, Rozman B, Hocevar A, et al. Incidence of primary Sjogren's syndrome in Slovenia. Ann Rheum Dis 2004;63:874-6. (Pubitemid 38850464)
3. Alamanos Y, Tsifetaki N, Voulgari PV, et al. Epidemiology of primary Sjögren's syndrome in north-west Greece, 1982-2003. Rheumatology (Oxford) 2006;45:187-91. (Pubitemid 43160081)
4. Weng MY, Huang YT, Liu MF, et al. Incidence and mortality of treated primary Sjogren's syndrome in Taiwan: a population-based study. J Rheumatol 2011;38:706-8.
5. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92. (Pubitemid 9087322)
6. Kauppi M, Pukkala E, Isomäki H. Elevated incidence of hematologic malignancies in patients with Sjögren's syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Causes Control 1997;8:201-4. (Pubitemid 27170375)
7. Valesini G, Priori R, Bavoillot D, et al. Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. J Rheumatol 1997;24:2376-80. (Pubitemid 28005139)
8. Davidson BK, Kelly CA, Griffiths ID. Primary Sjögren's syndrome in the North East of England: a long-term follow-up study. Rheumatology (Oxford) 1999;38:245-53. (Pubitemid 29507160)
9. Voulgarelis M, Dafni UG, Isenberg DA, et al. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome. Arthritis Rheum 1999;42:1765-72. (Pubitemid 30263648)
10. Pertovaara M, Pukkala E, Laippala P, et al. A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 2001;60:467-72. (Pubitemid 32417418)
11. Theander E, Henriksson G, Ljungberg O, et al. Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 2006;65:796-803. (Pubitemid 43799181)
12. Lazarus MN, Robinson D, Mak V, et al. Incidence of cancer in a cohort of patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2006;45:1012-5. (Pubitemid 44283059)
13. Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009;125:398-405.
14. Zhang W, Feng S, Yan S, et al. Incidence of malignancy in primary Sjogren's syndrome in a Chinese cohort. Rheumatology (Oxford) 2010;49:571-7.
15. Bureau of National Health Insurance. National health insurance profile 2010. http:// www.nhi.gov.tw/webdata/webdata.aspx?menu=17&menu-id= 659&webdata- id=3513&WD-ID=659 (accessed 2 November 2011).
16. Wu CY, Kuo KN, Wu MS, et al. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009;137:1641-8.e1.
17. Wu CY, Wu MS, Kuo KN, et al. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010;28:2952-7.
18. Chen HF, Chen P, Li CY. Risk of malignant neoplasms of liver and biliary tract in diabetic patients with different age and sex stratifications. Hepatology 2010;52:155-63.
19. Chen HF, Chen P, Li CY. Risk of malignant neoplasm of the pancreas in relation to diabetes: a population-based study in Taiwan. Diabetes Care 2011;34:1177-9.
20. Chen YJ, Chang YT, Wang CB, et al. The risk of cancer in patients with rheumatoid arthritis: a nationwide cohort study in Taiwan. Arthritis Rheum 2011;63:352-8.
21. Liang JA, LM Sun, Yeh JJ, et al. Malignancies associated with systemic lupus erythematosus in Taiwan: a nationwide population-based cohort study. Rheumatol Int Published Online First: 31 December 2010 doi:10.1007/s00296-010- 1684-y.
22. Huang YL, Chen YJ, Lin MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009;161:854-60.
23. Chen YJ, Wu CY, Huang YL, et al. Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis Res Ther 2010;12:R70.
24. Chen YJ, Chang YT, Wang CB, et al. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med 2010;123:1150.e1-6.
25. Bureau of National Health Insurance. Regulations for Exempting NHI Insured Persons from the Co-Payment. http://www.nhi.gov.tw/webdata/webdata. aspx?menu=17&menu-id=660&WD-ID=674&webdata-id=2431 (accessed 2 November 2011).
26. Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American- European Consensus Group. Ann Rheum Dis 2002;61:554-8. (Pubitemid 34539104)
27. Parikh-Patel A, White RH, Allen M, et al. Risk of cancer among rheumatoid arthritis patients in California. Cancer Causes Control 2009;20:1001-10.
28. Ota T, Wake A, Eto S, et al. Sjögren's syndrome terminating with multiple myeloma. Scand J Rheumatol 1995;24:316-8.
29. Rodriguez-Cuartero A, Salas-Galan A. Sjögren's syndrome and multiple myeloma. Eur J Cancer 1997;33:167-8.
30. Terpos E, Angelopoulou MK, Variami E, et al. Sjögren's syndrome associated with multiple myeloma. Ann Hematol 2000;79:449-51. (Pubitemid 30636262)
31. Kang JH, Lin HC. Comorbidities in patients with primary Sjogren's syndrome: a registry-based case-control study. J Rheumatol 2010;37:1188-94.
32. Lazarus MN, Isenberg DA. Development of additional autoimmune diseases in a population of patients with primary Sjögren's syndrome. Ann Rheum Dis 2005;64:1062-4. (Pubitemid 40909523)
33. Zeher M, Horvath IF, Szanto A, et al. Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome. Thyroid 2009;19:39-45.
34. Repplinger D, Bargren A, Zhang YW, et al. Is Hashimoto's thyroiditis a risk factor for papillary thyroid cancer? J Surg Res 2008;150:49-52.
35. Priori R, Iannuccelli C, Alessandri C, et al. Fatigue in Sjogren's syndrome: relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol 2010;28 (6 Suppl 63):S82-6.
36. Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007;369:1603-13. (Pubitemid 46710123)
37. Chan AT, Giovannucci EL, Meyerhardt JA, et al. Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 2008;134:21-8. (Pubitemid 350309311)